|
1
|
Haie-Meder C, Morice P and Castiglione M:
ESMO Guidelines Working Group: Cervical cancer: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21:(Suppl 5). v37–v40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Castellsagué X, Díaz M, de Sanjosé S,
Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS,
Snijders PJ, et al: International Agency for Research on Cancer
Multicenter Cervical Cancer Study Group: Worldwide human
papillomavirus etiology of cervical adenocarcinoma and its
cofactors: Implications for screening and prevention. J Natl Cancer
Inst. 98:303–315. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aranha MM, Santos DM, Xavier JM, Low WC,
Steer CJ, Solá S and Rodrigues CM: Apoptosis-associated microRNAs
are modulated in mouse, rat and human neural differentiation. BMC
Genomics. 11:5142010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwarzenbacher D, Balic M and Pichler M:
The role of microRNAs in breast cancer stem cells. Int J Mol Sci.
14:14712–14723. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lawrie CH, Gal S, Dunlop HM, Pushkaran B,
Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J,
Wainscoat JS, et al: Detection of elevated levels of
tumour-associated microRNAs in serum of patients with diffuse large
B-cell lymphoma. Br J Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ho AS, Huang X, Cao H, Christman-Skieller
C, Bennewith K, Le QT and Koong AC: Circulating miR-210 as a novel
hypoxia marker in pancreatic cancer. Transl Oncol. 3:109–113. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia XM, Jin WY, Shi RZ, Zhang YF and Chen
J: Clinical significance and the correlation of expression between
Let-7 and K-ras in non-small cell lung cancer. Oncol Lett.
1:1045–1047. 2010.PubMed/NCBI
|
|
10
|
Kong D, Heath E, Chen W, Cher ML, Powell
I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, et al: Loss of let-7
up-regulates EZH2 in prostate cancer consistent with the
acquisition of cancer stem cell signatures that are attenuated by
BR-DIM. PLoS One. 7:e337292012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mayr C, Hemann MT and Bartel DP:
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic
transformation. Science. 315:1576–1579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He XY, Chen JX, Zhang Z, Li CL, Peng QL
and Peng HM: The let-7a microRNA protects from growth of lung
carcinoma by suppression of k-Ras and c-Myc in nude mice. J Cancer
Res Clin Oncol. 136:1023–1028. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou J, Peng R, Li T, Luo X, Peng H, Zha
H, Yin P, Wen L and Zhang Z: A potentially functional polymorphism
in the regulatory region of let-7a-2 is associated with an
increased risk for diabetic nephropathy. Gene. 527:456–461. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ,
Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, et al: Altered MicroRNA
expression in cervical carcinomas. Clin Cancer Res. 14:2535–2542.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan DM, Tian XY, Wang RF and Yu JJ: The
prognosis significance of TGF-β1 and ER protein in cervical
adenocarcinoma patients with stage Ib~IIa. Tumour Biol.
35:11237–11242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chu GC, Dunn NR, Anderson DC, Oxburgh L
and Robertson EJ: Differential requirements for Smad4 in
TGFbeta-dependent patterning of the early mouse embryo.
Development. 131:3501–3512. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
López-Muñoz H, Escobar-Sánchez ML,
López-Marure R, Lascurain-Ledesma R, Zenteno E, Hernández-Vazquez
JM, Weiss-Steider B and Sánchez-Sánchez L: Cervical cancer cells
induce apoptosis in TCD4+ lymphocytes through the
secretion of TGF-β. Arch Gynecol Obstet. 287:755–763. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai X, He T, Liu J, Wang Y, Fan L, Tao K,
Shi J, Tang C, Su L and Hu D: Loureirin B inhibits fibroblast
proliferation and extracellular matrix deposition in hypertrophic
scar via TGF-β/Smad pathway. Exp Dermatol. 24:355–360. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng XH and Derynck R: Specificity and
versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev
Biol. 21:659–693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pasche B, Pennison MJ, Jimenez H and Wang
M: TGFBR1 and cancer susceptibility. Trans Am Clin Climatol Assoc.
125:300–312. 2014.PubMed/NCBI
|
|
21
|
Sun Y, Peng R, Peng H, Liu H, Wen L, Wu T,
Yi H, Li A and Zhang Z: miR-451 suppresses the NF-kappaB-mediated
proinflammatory molecules expression through inhibiting LMP7 in
diabetic nephropathy. Mol Cel Endocrinol. 433:75–86. 2016.
View Article : Google Scholar
|
|
22
|
Shishodia G, Shukla S, Srivastava Y,
Masaldan S, Mehta S, Bhambhani S, Sharma S, Mehrotra R, Das BC and
Bharti AC: Alterations in microRNAs miR-21 and let-7a correlate
with aberrant STAT3 signaling and downstream effects during
cervical carcinogenesis. Mol Cancer. 14:1162015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nair VS, Maeda LS and Ioannidis JP:
Clinical outcome prediction by microRNAs in human cancer: A
systematic review. J Natl Cancer Inst. 104:528–540. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shell S, Park SM, Radjabi AR, Schickel R,
Kistner EO, Jewell DA, Feig C, Lengyel E and Peter ME: Let-7
expression defines two differentiation stages of cancer. Proc Natl
Acad Sci USA. 104:11400–11405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Serguienko A, Grad I, Wennerstrøm AB,
Meza-Zepeda LA, Thiede B, Stratford EW, Myklebost O and Munthe E:
Metabolic reprogramming of metastatic breast cancer and melanoma by
let-7a microRNA. Oncotarget. 10:2451–2465. 2015. View Article : Google Scholar
|
|
26
|
Dong Q, Meng P, Wang T, Qin W, Qin W, Wang
F, Yuan J, Chen Z, Yang A and Wang H: MicroRNA let-7a inhibits
proliferation of human prostate cancer cells in vitro and in vivo
by targeting E2F2 and CCND2. PLoS One. 5:e101472010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhong Z, Dong Z, Yang L, Chen X and Gong
Z: Inhibition of proliferation of human lung cancer cells by green
tea catechins is mediated by upregulation of let-7. Exp Ther Med.
4:267–272. 2014.
|
|
28
|
Song H, Xu W, Song J, Liang Y, Fu W, Zhu
XC, Li C, Peng JS and Zheng JN: Overexpression of Lin28 inhibits
the proliferation, migration and cell cycle progression and induces
apoptosis of BGC-823 gastric cancer cells. Oncol Rep. 33:997–1003.
2015.PubMed/NCBI
|
|
29
|
Lee JY, Kim HJ, Yoon NA, Lee WH, Min YJ,
Ko BK, Lee BJ, Lee A, Cha HJ, Cho WJ, et al: Tumor suppressor p53
plays a key role in induction of both tristetraprolin and let-7 in
human cancer cells. Nucleic Acids Res. 41:5614–5625. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Akhurst RJ and Hata A: Targeting the TGFβ
signalling pathway in disease. Nat Rev Drug Discov. 11:790–811.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lei Z, Xu G, Wang L, Yang H, Liu X, Zhao J
and Zhang HT: MiR-142-3p represses TGF-β-induced growth inhibition
through repression of TGFβR1 in non-small cell lung cancer. FASEB
J. 28:2696–2704. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fang Y, Chen Y, Yu L, Zheng C, Qi Y, Li Z,
Yang Z, Zhang Y, Shi T, Luo J, et al: Inhibition of breast cancer
metastases by a novel inhibitor of TGFβ receptor 1. J Natl Cancer
Inst. 105:47–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
